Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
3.
Cutis ; 62(1): 23-6, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9675528

ABSTRACT

Spindle cell hemangioendothelioma (SCH) is a rare vascular neoplasm characterized by cavernous spaces, thrombi, phleboliths, and spindle cells. The lesions may arise at sites of vascular injury. We describe a 38-year-old man with multiple subcutaneous and penile SCHs. Patients with SCH should be screened for Maffucci's syndrome.


Subject(s)
Hemangioendothelioma/pathology , Penile Neoplasms/pathology , Soft Tissue Neoplasms/pathology , Adult , Humans , Leg , Male
5.
Phys Sportsmed ; 26(2): 104-8, 1998 Feb.
Article in English | MEDLINE | ID: mdl-20086784

ABSTRACT

A 24-year-old man presented to a dermatology clinic complaining of a "smelly" rash on his feet. The rash had developed during a period of intense training for a 20-km forced road march. He reported that the rash was asymptomatic, but that the odor was embarrassing at times.

6.
Cutis ; 60(3): 125-6, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9314615

ABSTRACT

A residential gardener complained of immediate stinging when a "fuzzy tan caterpillar" fell across his fingers. He presented with painful hemorrhagic papules on the dorsal aspect of his right hand. Lepidopterism from contact with Megalopyge opercularis is described.


Subject(s)
Dermatitis, Contact/etiology , Moths , Skin Diseases, Vesiculobullous/etiology , Aged , Agriculture , Animals , Hand Dermatoses/etiology , Hand Dermatoses/physiopathology , Humans , Larva , Male , Pain/etiology , Remission, Spontaneous , Skin Diseases, Vesiculobullous/physiopathology
7.
Anesth Analg ; 85(2): 372-9, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9249116

ABSTRACT

The pharmacologic effects of intrathecal sufentanil (ITS) beyond what is clinically administered (10 microg) are not known. We observed 18 healthy, young, adult female volunteers who received 12.5, 25, or 50 microg of ITS in a randomized, double-blind fashion for 11 h. Analgesia was assessed by pressure algometry at the tibia. Respiratory function was assessed by pulse oximetry, respiratory rate, arterial blood gas, the ventilatory response to CO2, and a respiratory intervention score (RIS). The incidence and severity of side effects also were documented. Serum sufentanil levels were measured for 4 h after ITS administration. We found that ITS produced statistically significant changes in algometry, doubling the pressure required to produce moderate pain. However, doses of ITS greater than 12.5 microg failed to produce proportionate increases in the duration or intensity of analgesia. All doses of ITS produced significant respiratory depression, but only the RIS was significantly related to ITS dose. Neither respiratory rate nor sedation reliably predicted hypoxemia. Supplemental oxygen by nasal cannula consistently prevented pulse oximeter readings below 90%. Serum sufentanil concentrations were related to ITS dose in a statistically significant manner, reached clinically significant concentrations, and followed a time course similar to analgesia and measures of respiratory depression. However, there was no significant increase in measured analgesia associated with the increases in serum sufentanil concentrations. We conclude that in our volunteer model of lower extremity pain, administering ITS in doses larger than 12.5 microg does not improve the speed of onset, magnitude, or duration of analgesia and only causes dose-related increases in serum sufentanil concentrations, which may augment respiratory depression.


Subject(s)
Analgesia, Epidural , Analgesics, Opioid/therapeutic use , Sufentanil/therapeutic use , Adult , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/adverse effects , Analgesics, Opioid/blood , Apnea/chemically induced , Apnea/prevention & control , Carbon Dioxide/blood , Conscious Sedation , Dose-Response Relationship, Drug , Double-Blind Method , Female , Forecasting , Humans , Hypoxia/chemically induced , Hypoxia/prevention & control , Incidence , Injections, Spinal , Nausea/chemically induced , Oximetry , Oxygen/blood , Oxygen Inhalation Therapy , Pain Measurement , Pressure , Pruritus/chemically induced , Reproducibility of Results , Respiration/drug effects , Sufentanil/administration & dosage , Sufentanil/adverse effects , Sufentanil/blood , Tibia , Time Factors , Vomiting/chemically induced
8.
J Anim Sci ; 75(5): 1256-65, 1997 May.
Article in English | MEDLINE | ID: mdl-9159272

ABSTRACT

Crossbred steers (n = 140; 353 kg) were implanted as follows: (C) control, no implant; (S) Synovex-S (20 mg estradiol benzoate + 200 mg progesterone); (R) Revalor (20 mg estradiol + 140 mg trenbolone acetate [TBA]; international dosage); (ST) S + finaplix-S (140 mg TBA); (STT) S + finaplix-S with finaplix-S reimplanted on d 58. Steers were harvested after 119 to 126 d on feed. Left sides of 40 carcasses were fabricated into boneless subprimals for two s.c. fat levels: 2.5 and .64 cm. Steers administered an estrogen (estradiol benzoate or estradiol) plus TBA gained more rapidly (P < .05) than C or S steers. Feed efficiency was improved (P < .05) with an estrogen plus TBA. No differences (P > .05) were noted among treatments for carcass s.c. fat thickness, percentage internal fat, or lean color. Carcasses from steers receiving TBA had larger (P < .05) longissimus areas and tended to have lower (P < .10) marbling scores and yield grades than C or S steers. Steers implanted with R had a lower (P < .05) percentage of U. S. Choice carcasses (51.8%) than C, S, and ST steers (82 to 86%). Shear force values for implanted steers tended to be higher (P < .10) than for controls. Implants increased (P < .05) subprimal and total side lean yields (.64 cm) compared to controls; the largest increases of 2.3 and 2.8%, respectively, occurred in steers receiving TBA plus an estrogen. Estrogen plus TBA exhibited favorable effects on gain, efficiency, and composition; however, the single estradiol plus TBA implant (R) decreased quality grade.


Subject(s)
Anabolic Agents/pharmacology , Body Composition/drug effects , Cattle/growth & development , Estradiol/analogs & derivatives , Estradiol/pharmacology , Meat/standards , Muscle, Skeletal/drug effects , Progesterone/pharmacology , Trenbolone Acetate/analogs & derivatives , Anabolic Agents/administration & dosage , Animals , Body Composition/physiology , Body Weight/physiology , Cattle/physiology , Cooking , Drug Combinations , Drug Implants , Estradiol/administration & dosage , Food Technology/methods , Hydrogen-Ion Concentration , Male , Muscle, Skeletal/physiology , Progesterone/administration & dosage , Trenbolone Acetate/administration & dosage , Trenbolone Acetate/pharmacology
9.
N Z Med J ; 109(1017): 69-72, 1996 Mar 08.
Article in English | MEDLINE | ID: mdl-8606821

ABSTRACT

AIMS: To describe differences between general practice prescribed and dispensed medications in terms of patient characteristics and category of drug. METHODS: Computerised prescribing records and prescriptions presented to pharmacies were retrospectively reviewed. All prescriptions generated from the computers of 13 practices over a 12 week period in 1992 were compared with prescriptions dispensed. Data from the two sources were matched and unmatched items were analysed to determine whether patient demography or category of drug prescribed influenced the rate of prescription dispensing. The nine most commonly prescribed drug categories were examined in detail. RESULTS: A total of 49 756 items were prescribed to 19 299 people and 43 302 (87.0%) of these were dispensed. Antibiotics were the most commonly prescribed category of the drug accounting for 17.6% of nondispensed items. There was no significant difference by gender in the proportion of people (9.8%) failing to claim prescribed items, nor in the number of items (13.0%) prescribed but not dispensed. Differences in dispensing rates by community services card (CSC) status of patients were statistically significant for both numbers of people failing to uplift their medications and for numbers of items not dispensed (p<0.001). There were also significant differences by high user health card (HUH) eligibility (p<0.005) and age (p<0.001). CONCLUSIONS: There is a high rate of nondispensing of medicines prescribed in general practice. Patients eligible for government subsidies are more likely than other patients to have their prescriptions filled. Current pharmaceutical subsidies may be inadequately targeted. There are no gender differences, while increasing age is associated with lower nondispensing rates. General practitioners need to be aware of these factors when making prescribing decisions.


Subject(s)
Drug Prescriptions , Treatment Refusal , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Child , Child, Preschool , Family Practice , Female , Humans , Infant , Insurance, Pharmaceutical Services , Male , Middle Aged , Practice Patterns, Physicians' , Retrospective Studies
10.
J Ultrasound Med ; 14(12): 913-7, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8583527

ABSTRACT

Peritoneal inclusion cysts have not received the attention they merit in the imaging literature. We present a series of peritoneal inclusion cysts and describe their sonographic features. Our findings lead us to encourage more conservative therapies. All seven patients in our series had pelvic pain and had undergone surgery previously. An ovary surrounded by septations and fluid was the most common finding by transvaginal sonography. Doppler examination showed low resistive flow in the septations. Conservative therapy was used in five cases with excellent results. We found that a confident diagnosis of peritoneal inclusion cysts is possible with ultrasonography. This diagnosis should encourage the use of more conservative therapy.


Subject(s)
Cysts/diagnostic imaging , Peritoneal Diseases/diagnostic imaging , Ultrasonography, Doppler , Adolescent , Adult , Ascitic Fluid/diagnostic imaging , Cysts/pathology , Diagnosis, Differential , Diagnostic Techniques, Surgical , Epithelium/pathology , Exudates and Transudates/diagnostic imaging , Female , Follow-Up Studies , Humans , Middle Aged , Ovary/diagnostic imaging , Pelvic Pain/diagnostic imaging , Pelvis/surgery , Peritoneal Diseases/pathology , Retrospective Studies , Tissue Adhesions/diagnostic imaging , Tissue Adhesions/pathology
11.
Circulation ; 65(6): 1072-7, 1982 Jun.
Article in English | MEDLINE | ID: mdl-6804108

ABSTRACT

The present study was designed to test the hypothesis that i.v. nitroglycerin is as effective as sodium nitroprusside for managing acute hypertension early after coronary artery bypass surgery. Seventeen patients received both nitroglycerin and nitroprusside in a randomized crossover protocol. Infusion rates were increased stepwise to lower mean arterial pressures comparably with each drug. In 14 of 17 patients, similar infusion rates of the two vasodilators resulted in equal lowering of both blood pressure and systemic vascular resistance. In the remaining three patients, very high infusion rates of nitroglycerin were required and achieved only 20-50% of nitroprusside's response in two of three. Hemodynamic responses to the two vasodilators were similar, except that nitroglycerin increased cardiac output more than nitroprusside did. In contrast, pulmonary gas exchange responses differed in that nitroglycerin improved intrapulmonary shunting, while nitroprusside worsened it. Similarly, nitroglycerin resulted in a significantly smaller increase in the alveolar arterial oxygen gradient than did nitroprusside. These results suggest that in the majority of patients, i.v. nitroglycerin was as effective as nitroprusside in controlling acute hypertension after coronary artery bypass surgery. In addition, nitroglycerin appeared to have more favorable effects on pulmonary gas exchange. Because nitroglycerin has more beneficial effects on intercoronary collateral blood flow in the setting of regional ischemia, it may be preferable to nitroprusside in patients with ischemic heart disease.


Subject(s)
Coronary Artery Bypass , Coronary Disease/surgery , Ferricyanides/therapeutic use , Hypertension/drug therapy , Nitroglycerin/therapeutic use , Nitroprusside/therapeutic use , Blood Pressure/drug effects , Cardiac Output/drug effects , Clinical Trials as Topic , Dose-Response Relationship, Drug , Humans , Infusions, Parenteral , Oxygen/blood , Postoperative Complications/drug therapy , Random Allocation , Vascular Resistance/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...